A detailed history of Artisan Partners Limited Partnership transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Artisan Partners Limited Partnership holds 3,133,412 shares of HALO stock, worth $147 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
3,133,412
Previous 3,717,264 15.71%
Holding current value
$147 Million
Previous $195 Million 7.9%
% of portfolio
0.28%
Previous 0.31%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$51.3 - $64.42 $30 Million - $37.6 Million
-583,852 Reduced 15.71%
3,133,412 $179 Million
Q2 2024

Aug 12, 2024

SELL
$37.81 - $52.4 $2.8 Million - $3.88 Million
-73,966 Reduced 1.95%
3,717,264 $195 Million
Q1 2024

May 13, 2024

SELL
$33.68 - $41.95 $97.6 Million - $122 Million
-2,897,828 Reduced 43.32%
3,791,230 $154 Million
Q4 2023

Feb 12, 2024

SELL
$33.32 - $42.1 $34.1 Million - $43.1 Million
-1,023,816 Reduced 13.27%
6,689,058 $247 Million
Q3 2023

Nov 09, 2023

BUY
$36.46 - $44.03 $9.24 Million - $11.2 Million
253,363 Added 3.4%
7,712,874 $295 Million
Q2 2023

Aug 10, 2023

BUY
$30.28 - $38.74 $14.2 Million - $18.1 Million
467,322 Added 6.68%
7,459,511 $269 Million
Q1 2023

May 11, 2023

SELL
$32.86 - $55.7 $4.89 Million - $8.29 Million
-148,764 Reduced 2.08%
6,992,189 $267 Million
Q4 2022

Feb 10, 2023

BUY
$40.06 - $59.44 $40.6 Million - $60.2 Million
1,013,061 Added 16.53%
7,140,953 $406 Million
Q3 2022

Nov 10, 2022

SELL
$38.53 - $51.78 $9.15 Million - $12.3 Million
-237,469 Reduced 3.73%
6,127,892 $242 Million
Q2 2022

Aug 12, 2022

SELL
$37.35 - $48.3 $109 Million - $141 Million
-2,920,325 Reduced 31.45%
6,365,361 $280 Million
Q1 2022

May 13, 2022

SELL
$31.97 - $41.06 $7.04 Million - $9.04 Million
-220,082 Reduced 2.32%
9,285,686 $370 Million
Q4 2021

Feb 11, 2022

SELL
$31.82 - $40.75 $18.2 Million - $23.3 Million
-570,845 Reduced 5.67%
9,505,768 $382 Million
Q3 2021

Nov 12, 2021

SELL
$38.47 - $46.42 $4.35 Million - $5.25 Million
-113,075 Reduced 1.11%
10,076,613 $410 Million
Q2 2021

Aug 12, 2021

SELL
$38.84 - $51.31 $10.8 Million - $14.3 Million
-278,471 Reduced 2.66%
10,189,688 $463 Million
Q1 2021

May 11, 2021

BUY
$39.51 - $51.45 $7.27 Million - $9.47 Million
184,023 Added 1.79%
10,468,159 $436 Million
Q4 2020

Feb 10, 2021

SELL
$25.81 - $43.62 $135 Million - $228 Million
-5,233,788 Reduced 33.73%
10,284,136 $439 Million
Q3 2020

Nov 12, 2020

SELL
$25.74 - $29.63 $33.2 Million - $38.2 Million
-1,289,489 Reduced 7.67%
15,517,924 $408 Million
Q2 2020

Aug 12, 2020

BUY
$16.25 - $26.81 $38.6 Million - $63.7 Million
2,377,376 Added 16.48%
16,807,413 $451 Million
Q1 2020

May 12, 2020

BUY
$13.9 - $21.83 $127 Million - $200 Million
9,169,541 Added 174.31%
14,430,037 $260 Million
Q4 2019

Feb 12, 2020

BUY
$14.93 - $19.53 $31.3 Million - $41 Million
2,099,753 Added 66.43%
5,260,496 $93.3 Million
Q3 2019

Nov 12, 2019

BUY
$15.2 - $17.69 $17.7 Million - $20.5 Million
1,161,380 Added 58.09%
3,160,743 $49 Million
Q2 2019

Aug 09, 2019

SELL
$14.75 - $17.26 $826,486 - $967,129
-56,033 Reduced 2.73%
1,999,363 $34.3 Million
Q1 2019

May 10, 2019

BUY
$13.94 - $17.58 $225,563 - $284,461
16,181 Added 0.79%
2,055,396 $33.1 Million
Q4 2018

Feb 12, 2019

SELL
$13.33 - $18.66 $1.64 Million - $2.29 Million
-122,657 Reduced 5.67%
2,039,215 $29.8 Million
Q3 2018

Nov 13, 2018

BUY
$16.68 - $18.41 $7.55 Million - $8.34 Million
452,852 Added 26.5%
2,161,872 $39.3 Million
Q2 2018

Aug 10, 2018

BUY
$16.87 - $20.3 $189,956 - $228,578
11,260 Added 0.66%
1,709,020 $28.8 Million
Q1 2018

May 10, 2018

BUY
$17.06 - $21.2 $800,233 - $994,428
46,907 Added 2.84%
1,697,760 $33.3 Million
Q4 2017

Feb 12, 2018

BUY
$16.75 - $20.8 $3.6 Million - $4.47 Million
214,967 Added 14.97%
1,650,853 $33.4 Million
Q3 2017

Nov 13, 2017

BUY
$11.76 - $17.4 $16.9 Million - $25 Million
1,435,886
1,435,886 $24.9 Million

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.54B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Artisan Partners Limited Partnership Portfolio

Follow Artisan Partners Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artisan Partners Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Artisan Partners Limited Partnership with notifications on news.